Skip to main content
Erschienen in: Endocrine Pathology 4/2016

01.06.2016

Detailed Lymph Node Sectioning of Papillary Thyroid Carcinoma Specimen Increases the Number of pN1a Patients

verfasst von: Felix Haglund, Stina Garvin, Catharina Ihre-Lundgren, Inga-Lena Nilsson, Evelina Hall, Tobias Carling, Anders Höög, C. Christofer Juhlin

Erschienen in: Endocrine Pathology | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

Papillary thyroid carcinoma (PTC) is a common endocrine malignancy, frequently presenting with lymph node metastasis at the time of diagnosis. Lymph node staging (N) partly determines treatment, follow-up, and prognosis. Since 2011, our institution has employed a more comprehensive histopathological work-up of lymph nodes in patients with PTC. We sought to retrospectively determine the value of serial lymph node level sectioning in PTCs with negative preoperative lymph node status (pN0) as a method to increase the sensitivity of detecting metastatic disease. We included all patients that underwent thyroidectomy and central neck dissection and subsequent comprehensive lymph node level sectioning due to PTC with an initial pN0 status between the years 2011 and 2015 at our institution. Sixty-seven cases of PTC with a median of 10 metastatic free lymph nodes identified per case were included. After serial lymph node sectioning of the central compartment, 11 cases (16 %) revealed lymph node metastasis, six of which (55 %) presented with a small primary tumor (<20 mm, T1). Of all T1 tumors with initial pN0 status, 18 % (T1a) and 9 % (T1b) reached a pN1 stage after comprehensive lymph node sectioning. Cases with altered lymph node status had a median of 15 identified lymph nodes as compared to ten in cases that remained negative. We conclude that comprehensive lymph node sectioning increased the sensitivity of detecting metastases in PTC and altered the pathological TNM staging (pTNM) for a significant number of patients. Although of limited prognostic significance, the method should be considered as an adjunct tool when assessing lymph node status of PTC as a part of the routine histological work-up to ensure an accurate cancer staging.
Literatur
1.
2.
Zurück zum Zitat Zaydfudim V, Feurer ID, Griffin MR, Phay JE (2008) The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma. Surgery 144:1070–1077.CrossRefPubMed Zaydfudim V, Feurer ID, Griffin MR, Phay JE (2008) The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma. Surgery 144:1070–1077.CrossRefPubMed
3.
Zurück zum Zitat American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167–1214.CrossRef American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167–1214.CrossRef
4.
Zurück zum Zitat Carling T, Carty SE, Ciarleglio MM, Cooper DS, Doherty GM, Kim LT, Kloos RT, Mazzaferri EL Sr, Peduzzi PN, Roman SA, Sippel RS, Sosa JA, Stack BC Jr, Steward DL, Tufano RP, Tuttle RM, Udelsman R; American Thyroid Association Surgical Affairs Committee (2012) American Thyroid Association design and feasibility of a prospective randomized controlled trial of prophylactic central lymph node dissection for papillary thyroid carcinoma. Thyroid 22:237–244.CrossRefPubMed Carling T, Carty SE, Ciarleglio MM, Cooper DS, Doherty GM, Kim LT, Kloos RT, Mazzaferri EL Sr, Peduzzi PN, Roman SA, Sippel RS, Sosa JA, Stack BC Jr, Steward DL, Tufano RP, Tuttle RM, Udelsman R; American Thyroid Association Surgical Affairs Committee (2012) American Thyroid Association design and feasibility of a prospective randomized controlled trial of prophylactic central lymph node dissection for papillary thyroid carcinoma. Thyroid 22:237–244.CrossRefPubMed
5.
Zurück zum Zitat Lang BH, Ng SH, Lau LL, Cowling BJ, Wong KP, Wan KY (2013) A systematic review and meta-analysis of prophylactic central neck dissection on short-term locoregional recurrence in papillary thyroid carcinoma after total thyroidectomy. Thyroid 23:1087–1098.CrossRefPubMed Lang BH, Ng SH, Lau LL, Cowling BJ, Wong KP, Wan KY (2013) A systematic review and meta-analysis of prophylactic central neck dissection on short-term locoregional recurrence in papillary thyroid carcinoma after total thyroidectomy. Thyroid 23:1087–1098.CrossRefPubMed
6.
Zurück zum Zitat Adam MA, Pura J, Goffredo P, Dinan MA, Reed SD, Scheri RP, Hyslop T, Roman SA, Sosa JA (2015) Presence and Number of Lymph Node Metastases Are Associated With Compromised Survival for Patients Younger Than Age 45 Years With Papillary Thyroid Cancer. J Clin Oncol 33:2370–2375.CrossRefPubMed Adam MA, Pura J, Goffredo P, Dinan MA, Reed SD, Scheri RP, Hyslop T, Roman SA, Sosa JA (2015) Presence and Number of Lymph Node Metastases Are Associated With Compromised Survival for Patients Younger Than Age 45 Years With Papillary Thyroid Cancer. J Clin Oncol 33:2370–2375.CrossRefPubMed
7.
Zurück zum Zitat Lundgren CI, Hall P, Dickman PW, Zedenius J (2006) Clinically important prognostic factors in patients with differentiated thyroid cancer. A population based nested case control study. Cancer 106:524–531.CrossRefPubMed Lundgren CI, Hall P, Dickman PW, Zedenius J (2006) Clinically important prognostic factors in patients with differentiated thyroid cancer. A population based nested case control study. Cancer 106:524–531.CrossRefPubMed
8.
Zurück zum Zitat Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (2010) AJCC cancer staging manual (7th ed). Springer, New York. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (2010) AJCC cancer staging manual (7th ed). Springer, New York.
10.
Zurück zum Zitat Cserni G (2002) Complete sectioning of axillary sentinel nodes in patients with breast cancer. Analysis of two different step sectioning and immunohistochemistry protocols in 246 patients. J Clin Pathol 55:926–931.CrossRefPubMedPubMedCentral Cserni G (2002) Complete sectioning of axillary sentinel nodes in patients with breast cancer. Analysis of two different step sectioning and immunohistochemistry protocols in 246 patients. J Clin Pathol 55:926–931.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Pargaonkar AS, Beissner RS, Snyder S, Speights VO Jr (2003) Evaluation of immunohistochemistry and multiple-level sectioning in sentinel lymph nodes from patients with breast cancer. Arch Pathol Lab Med 127:701–5.PubMed Pargaonkar AS, Beissner RS, Snyder S, Speights VO Jr (2003) Evaluation of immunohistochemistry and multiple-level sectioning in sentinel lymph nodes from patients with breast cancer. Arch Pathol Lab Med 127:701–5.PubMed
12.
Zurück zum Zitat Gietema HA, Vuylsteke RJ, de Jonge IA, van Leeuwen PA, Molenkamp BG, van der Sijp JR, Meijer S, van Diest PJ (2004) Sentinel lymph node investigation in melanoma: detailed analysis of the yield from step sectioning and immunohistochemistry. J Clin Pathol 57:618–620.CrossRefPubMedPubMedCentral Gietema HA, Vuylsteke RJ, de Jonge IA, van Leeuwen PA, Molenkamp BG, van der Sijp JR, Meijer S, van Diest PJ (2004) Sentinel lymph node investigation in melanoma: detailed analysis of the yield from step sectioning and immunohistochemistry. J Clin Pathol 57:618–620.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat DeLellis RA, Lloyd RV, Heitz PU, Eng C (2004) Tumours of endocrine organs. In: World Health Organization Classification of Tumour Pathology and Genetics. IARC Press, Lyon. DeLellis RA, Lloyd RV, Heitz PU, Eng C (2004) Tumours of endocrine organs. In: World Health Organization Classification of Tumour Pathology and Genetics. IARC Press, Lyon.
14.
Zurück zum Zitat Lang BH, Yih PC, Shek TW, Wan KY, Wong KP, Lo CY (2012) Factors affecting the adequacy of lymph node yield in prophylactic unilateral central neck dissection for papillary thyroid carcinoma. J Surg Oncol 106:966–971.CrossRefPubMed Lang BH, Yih PC, Shek TW, Wan KY, Wong KP, Lo CY (2012) Factors affecting the adequacy of lymph node yield in prophylactic unilateral central neck dissection for papillary thyroid carcinoma. J Surg Oncol 106:966–971.CrossRefPubMed
15.
Zurück zum Zitat Lang BH, Tang AH, Wong KP, Shek TW, Wan KY, Lo CY (2012) Significance of size of lymph node metastasis on postsurgical stimulated thyroglobulin levels after prophylactic unilateral central neck dissection in papillary thyroid carcinoma. Ann Surg Oncol 19:3472–3478.CrossRefPubMedPubMedCentral Lang BH, Tang AH, Wong KP, Shek TW, Wan KY, Lo CY (2012) Significance of size of lymph node metastasis on postsurgical stimulated thyroglobulin levels after prophylactic unilateral central neck dissection in papillary thyroid carcinoma. Ann Surg Oncol 19:3472–3478.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Mao LN, Wang P, Li ZY, Wang Y, Song ZY (2015) Risk factor analysis for central nodal metastasis in papillary thyroid carcinoma. Oncol Lett; 9:103–107.PubMed Mao LN, Wang P, Li ZY, Wang Y, Song ZY (2015) Risk factor analysis for central nodal metastasis in papillary thyroid carcinoma. Oncol Lett; 9:103–107.PubMed
17.
Zurück zum Zitat Gemsenjäger E, Perren A, Seifert B, Schüler G, Schweizer I, Heitz PU (2003) Lymph node surgery in papillary thyroid carcinoma. J Am Coll Surg 197:182–190.CrossRefPubMed Gemsenjäger E, Perren A, Seifert B, Schüler G, Schweizer I, Heitz PU (2003) Lymph node surgery in papillary thyroid carcinoma. J Am Coll Surg 197:182–190.CrossRefPubMed
18.
Zurück zum Zitat Randolph GW, Duh QY, Heller KS, LiVolsi VA, Mandel SJ, Steward DL, Tufano RP, Tuttle RM (2012) The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension. Thyroid 22:1144–1152.CrossRefPubMed Randolph GW, Duh QY, Heller KS, LiVolsi VA, Mandel SJ, Steward DL, Tufano RP, Tuttle RM (2012) The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension. Thyroid 22:1144–1152.CrossRefPubMed
Metadaten
Titel
Detailed Lymph Node Sectioning of Papillary Thyroid Carcinoma Specimen Increases the Number of pN1a Patients
verfasst von
Felix Haglund
Stina Garvin
Catharina Ihre-Lundgren
Inga-Lena Nilsson
Evelina Hall
Tobias Carling
Anders Höög
C. Christofer Juhlin
Publikationsdatum
01.06.2016
Verlag
Springer US
Erschienen in
Endocrine Pathology / Ausgabe 4/2016
Print ISSN: 1046-3976
Elektronische ISSN: 1559-0097
DOI
https://doi.org/10.1007/s12022-016-9438-3

Weitere Artikel der Ausgabe 4/2016

Endocrine Pathology 4/2016 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …